| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Revitalist Lifestyle and Wellness Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.000001 |
| 52 Week High | CA$0.039 |
| 52 Week Low | CA$0.000001 |
| Beta | 0 |
| 11 Month Change | n/a |
| 3 Month Change | n/a |
| 1 Year Change | -99.99% |
| 33 Year Change | -100.00% |
| 5 Year Change | n/a |
| Change since IPO | -100.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| RVLW.F | US Healthcare | US Market | |
|---|---|---|---|
| 7D | n/a | -1.2% | 0.3% |
| 1Y | -100.0% | 8.2% | 32.4% |
Return vs Industry: RVLW.F underperformed the US Healthcare industry which returned 9.5% over the past year.
Return vs Market: RVLW.F underperformed the US Market which returned 32.5% over the past year.
Price Volatility
| RVLW.F volatility | |
|---|---|
| RVLW.F Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 7.1% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in US Market | 15.0% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: RVLW.F's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine RVLW.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2018 | n/a | Kathryn Walker | revitalist.com |
Revitalist Lifestyle and Wellness Ltd. operates medical clinics. The company offers ketamine-enhanced psychotherapy, psychedelic-enhanced psychotherapy, medicative infusion therapy, vitamin infusions, transcranial magnetic stimulation, psychotherapy, and other medications focusing on mental health and acupuncture.
Revitalist Lifestyle and Wellness Ltd. Fundamentals Summary
| RVLW.F fundamental statistics | |
|---|---|
| Market cap | US$2.03m |
| Earnings (TTM) | -US$12.01m |
| Revenue (TTM) | US$4.67m |
0.0x
P/S Ratio0.0x
P/E RatioIs RVLW.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| RVLW.F income statement (TTM) | |
|---|---|
| Revenue | CA$4.67m |
| Cost of Revenue | CA$8.32m |
| Gross Profit | -CA$3.65m |
| Other Expenses | CA$8.36m |
| Earnings | -CA$12.01m |
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did RVLW.F perform over the long term?
See historical performance and comparison